QGEN: Qiagen N.V. Price to Earnings Adjusted for Growth Rate
Diversified consumable supplies between the US and Europe ensure the business stability of Qiagen N.V. (QGEN). The history of PEG ratios demonstrates the market valuation of the asset, where the current value is 3.05. The company's success is based on the synergy of global ambitions and an academic approach, while granting scientists broad research freedom reliably retains key experts on staff.
Qiagen NV (QGEN) - metric breakdowns and financial figures
- market value and analyst target forecast:
- market capitalization information:
- shareholders' equity book value data:
- issuer credit burden and liquidity indicators:
- net income and valuation multiples indicators:
QGEN - Net Profit|Projected Net Profit Qiagen N.V.|QGEN - P/E Multiple|Projected Price to Earnings Ratio qiagen.com|QGEN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Qiagen Corp|QGEN - Operating profit EBITDA|Earnings per share for the last 12 months Qiagen|QGEN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months qiagen.com|QGEN - Earnings growth in current year|Earnings growth forecast for next year Qiagen N.V.
- sales revenue and business income indicators:
Summary company analytics:Qiagen N.V. QGEN
This metric measures the efficiency of the share price relative to net income growth rates, adjusting the classic P/E for business development dynamics to identify fundamental undervaluation. An analysis of the weighted PEG ratio allows for an assessment of the stability of Qiagen N.V. (QGEN), where predictable scaling driven by recurring consumable sales and production automation creates a foundation for stable capitalization growth.
Who Qiagen N.V. competes with
PEG Multiple Tempus (TEM)|Price/Earnings to Growth Ratio ionispharma.com IONS|Growth-Adjusted Market Cap to Net Income Repligen Corporation (RGEN)|RNA: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio CRSP (CRISPR Therapeutics Corp)|WGS: PEG Multiple|Price to Earnings Adjusted for Growth Rate Ultragenyx Corp (RARE)|BEAM (Beam Therapeutics Inc) - PEG Multiple|SRPT: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Twist Bioscience Corp (TWST)|Price/Earnings to Growth Multiple 10x Genomics Inc TXG|Intellia Therapeutics, Inc. - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio STOK|BLFS - Price/Earnings to Growth Ratio|Wave Life Sciences (WVE) - Price/Earnings to Growth Multiple|MAZE: PEG Multiple|Sionna Therapeutics, Inc. (SION) - PEG Multiple|Price/Earnings to Growth Ratio Prime Medicine, Inc.|TSHA (Taysha) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple QURE (uniQure Pharma)|Growth-Adjusted Market Cap to Net Income meiragtx.com|Price/Earnings to Growth Ratio REGENXBIO RGNX|SLDB - Price/Earnings to Growth Multiple|Ocugen, Inc. - PEG Multiple|PACB (Pacific Biosciences of California) - Growth-Adjusted P/E Ratio|BNTC: PEG Multiple|DSGN - Growth-Adjusted Market Cap to Net Income|RCKT (Rocket Pharma) - PEG Multiple|Price/Earnings to Growth Ratio FDMT|Price/Earnings to Growth Ratio Lexeo Therapeutics, Inc. (LXEO)|Korro Bio Inc. - Growth-Adjusted P/E Ratio|editasmedicine.com - Price/Earnings to Growth Multiple|Growth-Adjusted Market Cap to Net Income silence-therapeutics.com (SLN)|PRQR: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate codexis.com|SGMO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Nautilus Biotechnology Inc (NAUT)|Price/Earnings to Growth Multiple MGX|DTIL (Precision BioSciences) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Ratio Generation Bio Corp (GBIO)|Boundless Bio - Growth-Adjusted P/E Ratio|Price/Earnings to Growth Ratio Exicure, Inc. XCUR|Growth-Adjusted Payback Ratio IMNN|PHIO - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income Mustang Bio Inc MBIO|RNAZ: PEG Multiple|Growth-Adjusted P/E Ratio BNGO|APDN (Applied DNA Sciences Inc) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Bluebird Bio BLUE|PEG Multiple IPA|Omega Therapeutics (OMGA) - Price to Net Income Growth Ratio|PEG Multiple OMIC (Singular Genomics Systems Inc)|Price to Net Income Growth Ratio Regulus Therapeutics Inc|SYRS - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio TBIO (Codex DNA)|TCON: PEG Multiple|UBX - Growth-Adjusted Market Cap to Net Income
